Business Context and Reporting Period
This Form 6-K filing by James Hardie Industries plc covers the month of November 2017. The registrant is a foreign private issuer headquartered in Dublin, Ireland, and files annual reports on Form 20-F. The primary purpose of this filing is to disclose the announcement of the acquisition of Fermacell (Exhibit 99.1).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure of a corporate event rather than a financial results report.
Material Changes
- Acquisition Announcement: The Company announced the acquisition of Fermacell, as detailed in Exhibit 99.1.
Guidance, Outlook, and Risks
The filing contains extensive forward-looking statements regarding future performance, capital expenditure projects, credit facilities, dividend payments, and share buy-backs. Management highlights significant risks and uncertainties, including:
- Asbestos Liabilities: Risks related to prior asbestos product manufacture, contributions to the Asbestos Injuries Compensation Fund (AICF), and potential shortfalls.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
- Market Conditions: Dependence on residential and commercial construction markets, housing values, and economic conditions in the US and Asia Pacific.
- Operational Risks: Supply and cost of raw materials, currency exchange rate fluctuations, and competition.
Investor Verification Checklist
- Review the full terms and financial impact of the Fermacell acquisition in Exhibit 99.1.
- Verify the Company's current asbestos liability estimates and AICF funding status in the most recent Form 20-F.
- Assess the Company's exposure to US housing market fluctuations and currency exchange rates.
- Confirm the status of pending legal proceedings and warranty provisions.